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75(4): 1477-1485, 1993.-Effects of carbohydrate (CHO) sup-V0 2 . ) increases insulin and plasma glucose concentraplementation on muscle glycogen utilization and endurance tions and maintains these variables at elevated levels were evaluated in seven well-trained male cyclists during conh tinuous cyclingexercisethat varied between low [45% maximal throughout the exercise bout (1 19 30) in contrast OX uptake (Vo 2 ,)] and moderate intensity (75% Vo 2 ). CHO supplementation during moderate-intensity exerDuring each exercise bout the subjects received either artifi-cise (i.e., 65-75% Vo 2 ,) only aids in the maintenance of cially flavoredplacebo (P), 10% liquid CHO supplement (L; 3 x plasma glucose and insulin concentrations (10) . 18 g CHO/h), or solid CHO supplement (S; 2 x 25 g CHO/h).
It is not currently known whether the ingestion of a Muscle biopsies were taken from vastus lateralig during P and CHO supplement will alter the rate of decline in muscle L trials immediately before exercise and after first (124 min) glycogen during exercise of alternating intensity. Howand second set (190 min) of intervals. Subjects then rode to ever, on the basis of our previous research (30), we hyfatigue at 80% Vo 2 -. Plasma glucose and insulin responses pothesized that moderate-intensity exercise interspersed during L treatment reached levels of 6.7 ± 0.7 mM and 70.6 ± with low-intensity exerclti elevaed 17.2 pU/ml, respectively, and were significantly greater than wIth low-intensity exercise would result in elevated those of P treatment (4.4 ± 0.1 mM and 17.7 ± 1.6 pU/ml) plasma insulin and glucose levels, which in turn would throughout the exercise bout. Plasma glucose and insulin re-increase reliance on blood glucose while reducing relisponses of S treatment were intermediate to those of L and P ance on muscle glycogen. Therefore, we compared the treatments. Times to fatigue for S (223.9 ± 3.5 min) and L effect of a 10% glucose polymer supplement and an arti-(233.4 ± 7.5 min) treatments did not differ but were signifi-ficially sweetened liquid placebo on muscle glycogen uticantly greater than that of P treatment (202.4 ± 9.8 min). After lization and CHO metabolism during exercise that varied the first 190 min of exercise, muscle glycogen was significantly between low (45% Va 2 .) and moderate (75% Vo 2 ) greater during L (79 ± 3.5 pmol/g wet wt) than during P treat-intensity. ment (58.5 ± 7.2 pmol/g wet wt). Furthermore, differences in muscle glycogen concentrations between L and P treatments it has previously been reported that blood glucose OXIafter 190 min of exercise and in time to fatigue for these treat-dation is unable to provide a sufficient amount of energy ments were positively related (r = 0.76, P < 0.05). These results to support high-intensity work late in exercise (6). Cogsuggest that CHO supplementation can enhance prolonged con-gan and Coyle (6) administered CHO supplements to tinuous variable-intensity exercise by reducing dependency on subjects during cycling exercise that alternated between muscle glycogen as a fuel source. moderate (60% Vo 2 ) and high (85% Vo 2 ) intensity.
They observed that the CHO supplements maintained exercise performance; glucose; insulin; carbohydrate oxidation; blood glucose levels and CHO oxidation but were unable maltodextrin; fructose to support exercise at an intensity >75% V0 2 -late in exercise. This finding suggested that adequate muscle glycogen stores must be available to support high-intenSUBSTANTiAL EVIDENCE ExSTu s that indicates that the sity exercise. Therefore, we further hypothesized that a ingestion of carbohydrate (CHO) supplements during reduction in muscle glycogen utilization resulting from prolonged endurance activities can delay the onset of fa-the CHO feedings should translate into an extended time tigue (7, 10, 11, 16, 19) . It has been observed that CHO to fatigue during high-intensity work late in exercise. To feedings delay the onset of fatigue during prolonged con-test-this hypothesis the exercise intensity was increased tinuous moderate-intensity exercise (i.e, 70% maximal to 80% Voa = after 200 min of the variable-intensity 02 uptake (Vo 2 i)] by preventing hypoglycemia and exercise, and time to fatigue was compared between the maintaining CHO oxidation rather than by reducing the liquid CHO supplement and artificially sweetened liquid rate of muscle glycogen utilization (10, 15) . However, we placebo treatments. have recently reported that the decline in muscle glycoLastly, it has been reported that a solid CHO supplegen is reduced when CHO supplements are provided dur-ment increases blood glucose and CHO oxidation and ing 2 h of cycling exercise at 50% Vo 2 (30). The differ-improves cycling sprint performance when compared ences in muscle glycogen responses elicited by a CHO with a water placebo (13, 16) . However, we are not aware supplement during moderate-and low-intensity steady-of any investigation that has directly assessed the meta- all subjects were given a detailed explanation of the pro-mined at rest, Vo, not determined at fatigue). t, Time of muscle biopsy. cedures to be used and the potential risks of the study, %Vo,., percent maximal 0, consumption. and all signed an informed consent form. The study was approved by the University's Institutional Review for analysis of 02 (Applied Electrochemistry S-3A/1, Board. Ametek, Pittsburgh, PA) and C02 (Applied ElectrochemExperimental design. Each subject completed three istry CD-3A, Ametek). Inspired volumes were measured randomly assigned treatments in which either an artifi-using a dry gas meter (Rayfield Equipment, Waitsfield, cially flavored and colored water placebo (P), a 10.0% VT). Analog outputs from these instruments were diliquid CHO polymer (L; Performance, Shaklee US, San rected to a laboratory computer for calculation of ventiFrancisco, CA), or a solid 25-g CHO (fructose-maltodex-lation, 02 consumption (Vo 2 ), C02 production, and respitrin) source (S; Energy Bar, Shaklee US) was provided ratory exchange ratio (R) every 30 s. The criteria used to during exercise. Immediately before the S and L trials, establish Vo 2 K were a plateau in Vo 2 with increasing the subjects received 1 g CHO /kg body wt of a 25% liquid exercise intensity and R > 1.10. The mean Vo 2 forthe CHO polymer (Performance, Shaklee US), whereas a group was 4.65 ± 0.1 1/min (71.4 ± 2.8 ml-kg.T-min-1). similar volume of the liquid placebo was provided immeApproximately 2 ml of venous blood were drawn while diately before the P trial. The addition of a liquid CHO the subject was seated on the ergometer before the start supplement before the ride was to maximize the glucose of the incremental test and at the end of each 2-min and insulin responses at the start of exercise and to en-stage. One-half milliliter of blood was deproteinized in 1 sure adequate CHO consumption (10) . Preliminary test-ml of cold 8% perchloric acid. The acid extract was recoving indicated that the use of the solid CHO source in this ered by centrifugation (1,000 g for 15 min) and subsemanner caused gastrointestinal discomfort. During exer-quently used for the enzymatic analysis of lactate (17) . cise, 180 ml of the P or L treatments were provided at 20 Each subject's blood lactate threshold was determined by min of exercise and every 20 mih thereafter. The S treat-graphing the blood lactate concentration vs. Vo 2 and dement was provided at 30 min of exercise and then every termining the percent V 2 .. at which blood lactate 30 min for the duration of the exercise bout. The subjects started to accumulate (20). The mean lactate threshold also ingested 270 ml of water with each bar during the S for the group was 64.7 ± 3.2 %Vo 2 treatment to standardized the hourly fluid consumption One week after the Vo 2 _., test the subjects reported to among the experimental trials. In addition to the re-the laboratory to perform a practice ride to adjust and/or quired fluid intake, the subjects were allowed ad libitum verify appropriate work rates for the experimental trials. water consumption during the three experimental trials. No blood samples or tissue samples were collected during The subjects performed each trial in a room maintained the practice ride. The cycling protocol is depicted in Fig.  between 23 and 25°C at the same time of day and on the 1 and is a modification of the protocol used by Brouns (5) same day of the week over a 3-wk period, to simulate a stage of the Tour de France. The regimen Preliminary testing. Each subject reported to the labo-consisted of cycling for 30 min at 45% Vo2_ , followed ratory before the start of the experiment for determina-by six repeated 16-min periods composed of cycling for 8 tion of their maximal aerobic power (V0 2 --) and lactate min at 75% Va 2 -and for 8 min at 45% Vo 2 .. The threshold. When the subjects reported to the laboratory, subjects then dismounted the ergometer and sat quietly a catheter was inserted into an antecubital vein, fitted for 12 min. This period of time was determined to be of with a three-way stopcock, and taped in place. The sub-sufficient duration to perform a muscle biopsy and stop jects then mounted a Monark Ergomedic 829E bicycle the bleeding before the subjects continued exercising. ergometer equipped with cipless pedals (Look) and rac-After the rest-biopsy period the subjects mounted the ing saddle and sat quietly for 5 min. The incremental test ergometer and cycled for 5 min at 45% Va 2 .. and then 5 protocol consisted of 2-min stages that were set to elicit min at 60% Vo 2 _ A period of intervals then began that 40, 50, 60, 70, 80, 90, 100, and 110% of the subjects' esti-were composed of nine repeated 6-min bouts of cycling mated Vo2,.. Subjects breathed through a Daniel's consisting of 3 min at 75% Vo, and 3 min at 45% valve, with expired gases directed to a mixing chamber Vo2 .. After this sequence of intervals the subjects dis-
mounted the ergometer for the second 12-min rest-fore the start of exercise and during exercise at the time biopsy period. The subjects then mounted the ergometer points indicated in Fig. 1 . Four milliliters of each blood and resumed cycling for 5 min at 45% Vo 2 ,, 5 min at sample were anticoagulated with 250 Ai EDTA (24 mg/ 60% VO.,' and concluded at 80% Vo 2 ,, until fatigue. ml, pH 7.4), and the plasma was separated by centrifugaFatigue was defined as the point when the subjects were tion (1,000 g, 40C). The plasma was split into equal porunable to maintain a cycling cadence of 50 rpm. During tions and stored at -80oC for subsequent measurement the exercise bout, thermal stress was reduced by main-of glucose, free fatty acids (FFA), and insulin. Plasma taining the laboratory temperature at 20-22 0 C and by was analyzed for glucose concentration with a glucose directing two floor fans toward the subjects.
analyzer (23A, Yellow Springs Instruments, Yellow The subjects were instructed to maintain a training log Springs, OH) and for FFA according to Novack (25). The and diet recall for 3 days before the practice session. insulin concentration was measured by radioimmunoasThese records were used to standardize the subjects' say (Ref. 14; Radioassay System Laboratories, Carson, physical activity and diets on the days before each experi-CA). One-half milliliter of blood was deproteinized in 1 mental trial. In addition, the subjects were instructed to ml of cold 8.0% perchloric acid and centrifuged (1,000 g, maintain the same training schedule over the 3 wk of the 4 0 C) for 15 min. The acid extract was then stored at experimental trials.
-80C for subsequent enzymatic analysis of lactate (17) . ExperimentalprotocoL The subjects reportedtothe labPercutaneous muscle biopsies were taken from the oratory after a 12-h fast during which time they were vastus lateralis and were divided into two pieces. One allowed to consume only water. On reporting to the labo-portion was quickly frozen in isopentane cooled in liquid ratory, body weight was obtained and a heart rate (HR) N 2 and stored at -80CC until analyzed for glycogen. For monitor (UNIQ Heartwatch model 8799, Computer In-glycogen determination, the biopsies were weighed and struments, Hempstead, NY) was secured in place on the homogenized in a 50% glycerol-20 mM Na2HPO, buffer chest. A catheter was inserted into an antecubital vein, (1:50 wt/vol, pH 7.4) that contained 0.5 mM EDTA, fitted with a three-way stopcock, and taped in place. The 0.02% bovine serum albumin, and 5 mM fl-mercaptoethsubjects mounted the ergometer and sat quietly for 10 anol. Homogenization was performed over an ice-water min before the commencement of the test. The subjects slush. Two hundred microliters of the homogenate were then performed the above-described exercise protocol added to 200 g of 2 N HCI and incubated at 1000C for 120 ( Fig. 1 ). On conclusion of the exercise bout, body weight min. The homogenate was cooled to room temperature was recorded. Muscle biopsies were obtained from the and neutralized with 434 8l of 1 N NaOH. The muscle vastus lateralis by the needle biopsy technique (2) for the glycogen concentration was determined enzymatically (26). P and L trials immediately before exercise, at 124 min of
The second piece of the biopsy sample was oriented in exercise, and at 190 min of exercise. The biopsies were mounting media (OCT compound, Fisher Scientific, obtained within the first 2 min of the subjects dismount-Pittsburgh, PA) and rapidly frozen in isopentane cooled ing the cycle ergometer. Muscle biopsies were not ob-to its freezing point in liquid N 2 and stored at -80°C. tained during the S trial.
Serial sections (10 pm) were cut at -200C in a cryostat The subjects were unaware as to whether they were on and were stained for myosin adenosinetriphosphatase acthe P or L trial because the two treatments were similar tivity (pH 4.54) (4) and for glycogen via the periodic acidin color, taste, and texture. However, it was not possible Schiff (PAS) reaction (27). Sections from each biopsy to administer the S treatment in a blinded manner. Dur-sample were magnified, and the intensity of the PAS ing each trial the subjects were not aware of their dura-staining in the individual muscle fibers was rated visually tion of riding or the time of day. Constant verbal encour-on a scale of 1 (negative) to 5 (darkly stained). L and P agement to cycle to exhaustion was given to the subjects biopsy sections from the same subject were always during the final exercise intensity (i.e., 80% Vo 2 . ). The stained at the same time and in the same vessel. Each results of the experiment were not discussed until all section contained an average of 226 ± 21 muscle fibers. subjects had completed the three experimental trials.
PAS stains were statistically analyzed by two proceSample collection and analyses. Ventilation, Vo 2 , CO 2 dures. First, the percentage of type I and II fibers stained production, and R were recorded with the respiratory gas a designated intensity (1 through 5) were compared beanalysis system previously described. During the first 30 tween the P and L treatments. Second, a relative estimin of exercise, the 8-min interval stages, and the final mate of the glycogen concentration of the type I and II exercise intensity (i.e., 80% Vo 2 ,_ ), 5-min respiratory fibers for the P and L treatments was computed by multigas collection periods began at 5, 25, 41, 49, 73, 81, 105, plying the visual rating scale (i.e., 1 to 5) by the percent-113, and 200 min of exercise. Respiratory gas collection age of fibers that exhibited the corresponding staining periods were limited to 3 min during the 3-min interval intensity. For example, if 10% of the type I fibers for a stages. These 3-min collection periods began at 145, 148, particular muscle section exhibited a staining intensity 163, 166, 181, and 184 min of exercise.
of 5, then 10 was multiplied by 5 to obtain the weighted HR was recorded immediately before the start of the value of 50. This procedure was repeated for each of the exercise bout and throughout exercise at the time points staining intensities in the type I and II muscle fibers. The indicated in Fig. 1 . Subjective ratings of perceived exer-weighted values for the type I and II muscle fibers were tion (3) were obtained during exercise as indicated in then summed seperately for each subject. The sum of the Fig. 1 .
weighted values was subsequently used to distingish difFive milliliters of venous blood were drawn while the ferences between the P and L treatments in the type I subjects were seated on the ergometer immediately be-and II muscle fibers. used to distinguish differences in time to fatigue among treatment based on mean weighted values (P < 0.01). treatments. Two-way analysis of variance was used to statistically analyze all biochemical (treatment X time) the P treatment (P: 24.7 ± 8.3% vs. L: 3.4 ± 1.0%; P < and histochemical (treatment X staining intensity) van-0.01) and more fibers being stained darkly for glycogen ables. Significant differences between means were deter-9 value fibr uri g t tatnt (P: 7 lyco4es mined using Newman-Kuels post hoc test. Differences Li.e., vlue of 5) during the L treatment (P: 7.4 ± 3.4% vs. were considered significant if P < 0.05 was obtained.
CHO SUPPLEMENTATION SPARES MUSCLE GLYCOGEN
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Plasma glucose, insulin, FFA, and blood lactate responses. As shown in Fig. 4 , plasma glucose was similar RESULTS among treatments before exercise, averaging 4.3 ± 0.1 Exercise performance. It was found that the S and L mM. Over the first 30 min of exercise plasma glucose rose treatments enabled subjects to exercise for a signifr-to 5.5 ± 0.3 mM during the S treatment and to 6.7 ± 0.7 cantly (P < 0.05) longer time than did the P treatment. mM during the L treatment but only slightly increased to Time to fatigue averaged 223.9 ± 3.5 and 233.4 ± 7.5 min 4.4 + 0.1 mM during the P treatment. By 30 min of exerfor the S and L treatments, respectively. In contrast, the cise the plasma glucose response during the L treatment mean time to fatigue during the P treatment was 202.4 ± was significantly greater than that which occurred dur-9.8 min.
ing the P treatment. In addition, the L treatment mainGlycogen concentration in the. uastus lateralis muscle. tained the plasma glucose concentration at a signifiMuscle glycogen did not differ between the P and L cantly greater level throughout exercise than the P treattreatments before exercise and at 126 min of exercise ment except at 151 and 200 min of exercise. An (Fig. 2) . However, at 190 min of exercise muscle glycogen unanticipated finding was that even though a similar levels were significantly greater during the L treatment amount of CHO was administered during the S and L than the P treatment (Fig. 2) . Furthermore, it was ob-treatments the plasma glucose response of the L treatserved that the difference in muscle glycogen levels between the P and L trials at 190 min of exercise was posit. p tively correlated (r = 0.76, P < 0.05) to the difference in t -time to fatigue between these trials. 7
1 As a result of the difference in muscle glycogen concentration between the P and L treatments at 190 min of 6 exercise, PAS and myosin adenosinetriphosphatase stainings were performed to assess possible differences iE S in response between type I and II muscle fibers (Fig. 3) .
*
On the basis of the weighted values for the PAS stains, it 4 was found that the glycogen concentration of the type I fibers of the L treatment (393.3 ± 18.2 pmol/g) was signif-3 icantly greater than that of the P treatment (314.5 ± 20.9 ,zmol/g) at 190 min of exercise (P < 0.01). However, no type I muscle fibers was largely because of more fibers means ± SE. * Significantlycdifferent from P (P< 0.05); t significantly being stained lightly for glycogen (i.e., value of 2) during differenL from S (P < 0.05).
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the FFA levels declined during the S and L treatments, r wvhereas the P treatment produced a slight rise in FFA so min of exercise) and L treatments.
FIG. 5. Plasma insulin concentration during prolonged continuous
Va,, R, and CHO oxidation. Vo 2 (Table 2 ) was similar variable-intensity exercise. Values are means ± SE. * Significantly dif-among treatments during both the low-(-2.1 1/min) and ferent from P (P < 0.05); t significantly different from S (P < 0.05).
moderate-intensity intervals (-3.4 I/min). Over time, Vo 2 did not increase more than 0.1 I/min during either ment was significantly greater than that of the S treat-the low or moderate exercise intensities. During the final ment from 46 to 118 min of exercise. Furthermore, the high-intensity bout of exercise, Vo 2 was similar among plasma glucose response duringthe S treatmentwas simi-treatments, averaging -3.7 I/min. lar to the P treatment except at 166, 169, 184, and 187 R was not different among treatments at 10 min of min of exercise and at fatigue.
. exercise (Table 2) . However, by 30 min of exercise R was In response to the increased plasma glucose during the significantly greater during the S (0.91 ± 0.01) and L L treatment, the plasma insulin concentration increased (0.91 ± 0.01) treatments than during the P treatment from 19.4 ± 2.3 ,U/ml at rest to 70.6 ± 17.2 pU/ml after (0.87 ± 0.01). R was found to be maintained at a signifi-30 min of exercise (Fig. 5) . This plasma insulin concen-cantly greater level throughout exercise during the L tration was significantly different from that of the P treatment than during the P treatment. In addition, the treatment (16.0 ± 1.3 pU/ml). During the remainder of L treatment maintained R at a significantly greater level the exercise bout, the plasma insulin response gradually than did the S treatment at 151, 169, and 187 min of declined but remained significantly greater than that of exercise. Over the first 126 min of exercise, R was signifithe P treatment at all time points. The plasma insulin cantly greater during the S treatment than during the P response of the L treatment was also significantly treatment but only during the moderate-intensity intergreater than that of the S treatment at 78, 86, and 110 vals. However, over the next 64 min of exercise R was min of exercise. Plasma insulin levels did not differ be-greater during the S treatment than during the P treattween the P and S treatments except at 184 and 200 min ment at all time points except at 187 min of exercise. of exercise and at fatigue.
During the final bout of high-intensity exercise, R was Blood lactate was similar among treatments before ex-significantly greater during the S and L treatments than ercise, averaging 0.8 ± 0.1 mM' (Table 1) . At 30 min of during the P treatment. Vo 2 and R were used to estimate exercise blood lactate was -1.1 mM for all treatments. the rate of CHO oxidation, which is presented in Table 2 . Over the next 96 min of variable-intensity exercise the Because Vo 2 was not different among treatments, the blood lactate concentration reflected the changing exer-patterns of CHO oxidation generally paralleled the R recise intensity. During low-intensity exercise, blood lac-sponses. tate levels were near 1.6 mM, whereas moderate-intenFluid consumption and weight loss during exercise. sity exercise produced a blood lactate concentration that Fluid consumption did not differ among treatments. The was elevated to near 2.7 mM. During the second set of average fluid consumption was 750.0 ± 47.5,778.1 ± 47.0, variable-intensity exercise (i.e., the next 64 min of exer-and 809.4 ± 64.5 ml/h for the P, S, and L treatments, cise), the blood lactate concentration continued to reflect respectively. Similarly, the subjects' total and average the changes in exercise intensity, but the magnitude of hourly weight losses did not differ among treatments difference in blood lactate levels between the low and during exercise. Total body weight loss was 0.99 ± 0.16, moderate exercise intensity was not as large compared 0.87 ± 0.15, and 0.99 ± 0.23 kg for the P, S, and L treatwith the previous 96 min of exercise. Most likely, this ments, respectively. The average hourly weight loss was difference in blood lactate response was related to the 0.30 ± 0.05, 0.23 ± 0.03, and 0.26 ± 0.06 kg/h for the P, S, shorter interval durations, which may not have provided and L treatments, respectively. sufficient time to allow blood lactate to fully accumulate HR and perceived exertion. The exercise HR response in venous blood. No difference in blood lactate levels was was found to reflect the changes in exercise intensity. found among treatments except at fatigue. At fatigue During the low-intensity exercise bout HR was near 130 blood lactate was significantly elevated during the S beats/min, whereas during the moderate-intensity bout (5.22 ± 0.68 mM) and L (5.05 ± 0.80 mM) treatments of exercise HR increased to -160 beats/min. This patcompared with the P treatment (3.00 ± 0.42 mM).
tern remained consistent throughout exercise, with no Plasma FFA concentrations were similar among treat-difference in the HR response being detected among ments before exercise (Table 1) . By 30 min of exercise treatments except at fatigue. At fatigue the HR response 
was significantly greater during the S (178 ± 2 beats/ uted to reducing the decline in exercise muscle glycogen min) and L (181 ± 3 beats/min) treatments than during utilization. Our previous investigation utilized continuthe P treatment (166 ± 5 beats/min). ous low-intensity exercise, whereas our present investiThe subjects did not perceive any difference in effort gationwascomposedofcontinuousvariablelow-tomodduring exercise as a result of the treatments. However, erate-intensity exercise. It appears that these types of the subjects' ratings of effort did reflect the alterations in activities, as opposed to continuous moderate-intensity exercise intensity. During low-intensity exercise, the exercise, allow CHO feedings to generate hyperinsulemia subjects found the exercise to be relatively easy, although and hyperglycemia of a sufficient magnitude to reduce perceived exertion rose from -9 units (very light) at 30 exercise muscle glycogenolysis. Furthermore, elevations min of exercise to near 12 units (fairly light) by 184 min in both plasma glucose and insulin levels seem necessary of exercise. On the other hand, the moderate-intensity to reduce exercise muscle glycogen utilization, since hyexercise was perceived by the subjects to require an effort perglycemia alone does not appear to be a sufficient stimthat elicited a rating of-13 units (somewhat light) at 54 ulus. Coyle et al. (12) reported that the maintenance of min of exercise, which then rose to near 15 units (hard) at blood glucose levels at 10 mM by glucose infusion did not 187 min of exercise. At fatigue the average rating of per-reduce exercise muscle glycogenolysis during 2 h of conceived exertion was just under 20 units (very very hard) tinuous moderate-intensity exercise (73% Vo 2 .,,). for all treatments.
These investigators observed that plasma insulin levels were similar during the glucose infusion and control
DISCUSSION
trials until 60 min of exercise. In addition, peak insulin levels that reached only 24 ,U/ml were not achieved until In the present investigation we observed that the L 80 min of exercise during the glucose infusion trial and treatment reduced the rate of decline in muscle glycogen then were observed to decline over the last 40 min of concentration during exercise compared with the P exercise. treatment. Muscle glycogen concentration during the L The reduced decline in exercise muscle glycogen utilitreatment was slightly greater than but not significantly zation that was observed during the L treatment apdifferent from the P treatment at 126 min of exercise. peared to result from muscle glycogen sparing. HistoHowever, by 190 min of exercise the L treatment had chemical analysis of the muscle biopsies obtained at 190 maintained muscle glycogen at a concentration that was min of exercise indicated that the L treatment, compared -35% greater than that of the P treatment. We have with the P treatment, substantially reduced muscle glypreviously reported that the ingestion of liquid CHO sup-cogen utilization in the type I but not the type 11 muscle plements during low-intensity exercise (50% Vo 2 .. s) re-fibers. The low-intensity exercise utilized in the present sults in a sparing of muscle glycogen (30). These findings investigation would be expected to recruit primarily type are in contrast to those of recent investigations that have I muscle fibers, whereas the moderate-intensity exercise demonstrated that CHO supplementation had no influ-would be expected to recruit both type I and type II musence over muscle glycogen utilization during moderate-cle fibers. It has been suggested that muscle glycogen intensity exercise (70% Vo 2 m.) (10, 15) . synthesis can occur during low-intensity exercise if the These differences in muscle glycogen utilization in re-muscle is glycogen depleted and if CHO is ingested (8, sponse to CHO supplementation during exercise are Pos-22); however, this synthesis is restricted to nonactive sibly due to differences in plasma glucose and insulin muscle fibers (i.e., fast-twitch fibers) (22). Because the responses. During moderate-intensity exercise CHO concentration of glycogen in the type II muscle fibers at supplementation prevents the decline in plasma glucose 190 min of exercise did not differ between treatments, and insulin concentrations (10), whereas during low-in-this would suggest that muscle glycogen synthesis did not tensity exercise plasma glucose and insulin levels become account for the difference in muscle glycogen levels beelevated (1, 19, 30) . In the present investigation, we tweentretme Rather, i isclelyth te geaer found that the L treatment rapidly increased plasma glu-tween treatments. Rather, g t is lkely that the greater cose and insulin levels by 30 min of exercise and cni concentration of muscle glycogen at 190 min of exercise ued to maintain these variables at a greater concentra-during the L treatment was due primarily to muscle glytion throughout exercise than those of the P treatment. cogen sparing, since the type I muscle fibers were probaMost noteworthy, however, were the magnitudes of in-bly active throughout the exercise bout. This hypothesis crease in the plasma glucose and insulin concentrations is consistent with our previous investigation (30) in in response to the L treatment. The L treatment in-which we reported that CHO feedings reduced the decreased plasma glucose levels to 627 ± 0.7 mM and insulin cline in muscle glycogen during low-intensity exercise by concentrations to 70.6 ± 17.2 U/ml by 30 min of exercise reducing the rate of muscle glycogen utilization in slowand prevented plasma glucose and insulin levels from twitch muscle fibers (type I muscle fibers). falling below 5.0 mM and 30 pU/ml, respectively, over
The L treatment was found to significantly increase the following 80 min of exercise. These are the highest time to fatigue compared with the water placebo. This plasma insulin and glucose concentrations in response to finding is in agreement with a number of previous inves-CHO feedings during exercise that we are aware of hav-tigations that have documented that the ingestion of ing been reported.
CHO supplements during prolonged exercise can comIn our present and previous investigations (30), we ob-pensate for the reduction of endogenous CHO stores and served that plasma insulin and glucose levels became rap-delay the onset of fatigue (6, 7, 10, 11, 16, 19, 29) . The idly elevated in response to CHO feedings and contrib-manner by which CHO feedings delay the onset of fatigue during prolonged continuous moderate-intensity exer-(9). Furthermore, it has been observed that the rate of cise is by preventing hypoglycemia and maintaining intestinal absorption for glucose polymers is more rapid CHO oxidation rather than by reducing the decline in than that for glucose (21) , whereas fructose is absorbed muscle glycogen levels (10, 15, 28) . However, Coggan and from the intestine at a much slower rate than is glucose Coyle (6) have reported that blood glucose oxidation can- (18) . Thus, it is possible that the difference in plasma not fully support high-intensity work late in exercise glucose and insulin responses between the L and S treatwhen muscle glycogen stores are presumed to be de-ments was due to differences in the rate of intestinal pleted. We found that after 200 min of the variable-in-absorption of the supplements. tensity exercise the subjects were only capable of perIn summary, we observed that the S and L treatments forming -2 min of exercise at a very high exercise inten-significantly delayed the onset of fatigue during prosity (80% Vo 2 m.,) during the P treatment. In contrast, longed continuous variable-intensity exercise compared the L treatment allowed subjects to exercise for -33 min with the P treatment. In response to the S and L treatat 80% V02 m.n, Because it has previously been reported ments, plasma glucose, insulin, and CHO oxidation were hilt. blood glucosc oxidation cannot support exercise at elevated during exercise compared with the P treatment. an intensity >75% Vo 2 ma. late in exercise (6), it is un-However, the plasma glucose and insulin responses that likely that the L treatment would have been capable of occurred during the S treatment were intermediate to significantly extending time to fatigue during exercise at those of the P and L treatments. The difference in 80% VO. .. without adequate muscle glycogen stores. plasma glucose and insulin responses between the S and Thus, the substantial increase in time to fatigue at a very L treatments were likely related to the composition of intense work load late in exercise would further support the CHO supplements. Furthermore, it was observed our observation that muscle glycogen utilization was re-that the L treatment significantly reduced the rate of duced during the first 190 min of the L treatment.
decline in muscle glycogen utilization compared with A second purpose of this investigation was to examine that of the P treatment and could account for -60% of whether consuming a solid CHO supplement during pro-the improved time to fatigue during the L treatment. The longed continuous variable-intensity exercise would pro-reduced rate of decline in muscle glycogen during the L vide an ergogenic effect. Previous investigations have treatment most likely resulted from the elevated plasma compared the effects of solid CHO feedings with a water glucose and insulin levels that occurred during the variplacebo with respect to exercise metabolism and sprint able low-to moderate-intensity exercise. These results performance (13, 16) . However, we are not aware of any suggest that CHO supplementation can enhance aerobic investigations that have examined the effect of solid endurance during prolonged continuous exercise of vary-CHO feedings on exercise performance or metabolism ing low to moderate intensity in part by reducing dependuring prolonged continuous variable-intensity exercise. dency on muscle glycogen as a fuel source.
We observed that the S treatment was capable of sigWe thank Ho 
